Abstract
OBJECTIVE: To evaluate the relationship between insulin, the renin-aldosterone system and blood pressure in obese subjects.
DESIGN AND METHODS: A cross sectional study of a group of severely obese normotensive subjects who were surgical candidates (n=39; mean BMI: 47.8±1.4) and a group of hypertensive patients (n=57; mean BMI: 28.0±0.7) twenty-nine of whom had BMI>27. All subjects were studied after 15 days on a balanced diet. Insulin, plasma renin activity and aldosterone were measured.
RESULTS: Fasting insulin, plasma renin activity and aldosterone were higher in severely obese normotensive subjects than in hypertensive subjects (respectively 32.3±3.0 vs 13.1±1.0 mU/l, P=0.0001; 1.34±0.22 vs 0.88±0.12 ng/ml/h, P=0.04; 137.2±16.2 vs 87.9±12.1 pg/ml, P=0.015). Insulin was related to BMI and to aldosterone both in normotensive and in hypertensive patients.
CONCLUSION: Hyperinsulinemia itself does not determine hypertension; in some people it could play a vasodilator role in opposition to the renin-aldosterone system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berchtold P, Jorgens V, Finke C, Berger M . Epidemiology of obesity and hypertension Int J Obes 1981 5 (Suppl 1): 1–7.
Chiang BW, Perlman LV, Epstein FH . Overweight and hypertension: a review Circulation 1969 39: 403–421.
Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M . Weight and hypertension Ann Intern Med 1983 98: 855–859.
Jones DW, Kim JS, Andrew ME . Body mass index and blood pressures in Korean men and women: the Korean National Blood Pressure Survey J Hypertens 1994 12: 1433–1437.
Singh RB, Beegom R, Ghosh S, Niaz MA, Rastogi V, Rastogi SS, Singh NK, Nangia S . Epidemiological study of hypertension and its determinants in an urban population of North India J Hum Hypertens 1997 11: 679–685.
Kanai H, Matsuzawa Y, Tokunaga K, Keno Y, Kobatake T, Fujioka S, Nakajima T, Tarui S . Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure Int J Obes 1990 14: 1047–1056.
Weidmann P, Böhlen L and de Courten M . Insulin resistance and hyperinsulinemia in hypertension J Hypertens 1995 13 (Suppl 2): S65–S72.
Goodfriend TL, Egan BM, Kelley DE . Aldosterone in obesity Endocr Res 1998 24: 789–796.
Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara MA, Merlino G, Cecala MG . Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects Am J Hypertens 1994 7: 314–320.
Marks P, Wilson B, Delasalle A . Aldosterone studies in obese patients with hypertension Am J Med Sci 1985 289: 224–228.
Miyazaki Y, Shimamoto K, Ise T, Shiiki M, Higashiura K, Hirata A, Masuda A, Nakagawa M, Imura O . Effects of hyperinsulinaemia on renal function and the pressor system in insulin-resistant obese adolescents Clin Exp Pharmacol Physiol 1996 23: 287–290.
Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M . The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients New Engl J Med 1981 304: 930–933.
Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM . The relation of adiposity to blood pressure and development of hypertension. The Framingham Study Ann Intern Med 1967 67: 48–59.
Eliahou HE, Iaina A, Gaon T, Shochat J, Modan M . Body weight reduction necessary to attain normotension in the overweight hypertensive patient Int J Obes 1981 5 (Suppl 1): 157–163.
Kirschner MA, Schneider G, Ertel NH, Gorman J . An eight-year experience with a very-low-calorie formula diet for control of major obesity Int J Obes 1988 12: 69–80.
World Health Organization International Society of Hypertension Guidelines for the Management of Hypertension . Guidelines Subcommittee J Hypertens 1999 17: 151–183.
Bao W, Srinivasan SR, Wattigney WA, Berenson GS . The relation of parental cardiovascular disease to risk factors in children and young adults. The Bogalusa Heart Study Circulation 1995 91: 365–371.
Horswill CA, Zipf WB . Elevated blood pressure in obese children: influence of gender, age, weight and serum insulin levels Int J Obes 1991 15: 453–459.
Reaven GM . Role of insulin resistance in human disease Diabetes 1988 37: 1595–1607.
Berne C, Fagius J, Pollare T, Hjemdahl P . The sympathetic response to euglycemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects Diabetologia 1992 35: 873–879.
Rowe JW, Young JB, Minaker KL, Stevens AL, Palotta JA, Landsberg L . Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man Diabetes 1981 30: 219–225.
De Fronzo RA, Goldberg M, Agus ZS . The effects of glucose and insulin on renal electrolyte transport J Clin Invest 1976 58: 85–90.
Andronico G, Ferrara L, Mangano MT, Mulè G, Cerasola G . Insulin, Na, Li-countertransport and microalbuminuria in hypertensive patients Hypertension 1998 31: 110–113.
Andronico G, Mulè G, Mangano MT, Piazza G, Donatelli M, Cerasola G, Bompiani GD . Insulin resistance and endogenous digoxin-like factor in obese hypertensive patients with glucose intolerance Acta Diabetol 1992 28: 203–205.
Sowers JR, Sowers PS, Peuler JD . Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis J Lab Clin Med 1994 123: 647–652.
Stout RW, Bierman EL, Ross R . Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells Circ Res 1975 36: 319–327.
Tuck ML, Sowers J, Dornfield L . The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients New Engl J Med 1981 304: 930–933.
Goodfriend TL, Egan B, StepniaKowski K, Ball DL . Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans Hypertension 1995 25: 30–36.
Ferranini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G . Insulin resistance and hypersecretion in obesity J Clin Invest 1997 100: 1166–1173.
Berglund G, Andersson O . Body composition, metabolic and hormonal characteristics in unselected male hypertensives Int J Obes 1981 5 (Suppl 1): 143–150.
Kinoshita J, Tanaka Y, Niwa M, Yoshii H, Takagi M, Kawamori R . Impairment of insulin-induced vasodilation is associated with muscle insulin resistance in type 2 diabetes Diabetes Res Clin Pract 2000 47: 185–190.
Schmetterer L, Muller M, Fasching P, Diepolder C, Gallenkamp A, Zanaschka G, Findl O, Strenn K, Mensik C, Tschernko E, Eichler HG, Wolzt M . Renal and ocular hemodynamic effects of insulin Diabetes 1997 46: 1868–1874.
Acknowledgements
This work was partially funded by MURST (Ministero per l'Università e la Ricerca Scientifica e Tecnologica) with ‘60% quotas’.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andronico, G., Cottone, S., Mangano, M. et al. Insulin, renin-aldosterone system and blood pressure in obese people. Int J Obes 25, 239–242 (2001). https://doi.org/10.1038/sj.ijo.0801483
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801483
Keywords
This article is cited by
-
A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension
Journal of Human Hypertension (2014)
-
Aldosterone and cardiovascular risk
Current Hypertension Reports (2009)
-
Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome
American Journal of Hypertension (2008)
-
1, 25‐Dihydroxyvitamin D3 Modulation of Adipocyte Glucocorticoid Function
Obesity Research (2005)